Philadelphia-negative Acute Lymphoblastic Leukemia

• CLINICAL_TRIALS trial_result · 2026-04-16
  Clinical Trial Update: Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy [Phase 2]

  This phase 2 clinical trial update assesses the efficacy and safety of Besponsa (inotuzumab ozogamicin) in adults with Philadelphia-negative…

• CLINICAL_TRIALS trial_result · 2026-02-10
  Clinical Trial Update: A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL) [Phase 1]

  A Phase 1 study of 19-28z/IL-18 in adults with acute lymphoblastic leukemia is ongoing, including Philadelphia-negative and Philadelphia-pos…

• CLINICAL_TRIALS trial_result · 2021-05-07
  Clinical Trial Update: Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study [Phase 2]

  Phase II clinical trial update exploring pediatric-type therapy with pre-transplant blinatumomab for high-risk Philadelphia-negative acute l…